{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":36,"n_cols":5,"rows_kept":36,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[8,4,8,5],[9,2,9,3],[9,4,9,5],[10,2,10,3],[11,2,11,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[27,2,27,3],[28,2,28,3],[32,2,32,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISOBE600200014363"]
[null,null,"Autore",null,"Knight, Rex"]
[null,null,"Titolo",null,"A modern introduction to psychology / Rex Knight and Margaret Knight"]
[null,null,"Pubbl/distr/stampa",null,"London, : University Tutorial Press, 1961"]
[null,null,"Descrizione fisica",null,"272 p. ; 18 cm"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910960683203321"]
[null,null,"Titolo",null,"Developing new contraceptives : obstacles and opportunities / / Luigi Mastroianni, Jr., Peter J. Donaldson, and Thomas T. Kane, editors"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academy Press, 1990"]
[null,null,"ISBN",null,"9786610212828"]
[{"$nulls":4},"9781280212826"]
[{"$nulls":4},"1280212829"]
[{"$nulls":4},"9780309564526"]
[{"$nulls":4},"0309564522"]
[{"$nulls":4},"9780585155203"]
[{"$nulls":4},"0585155208"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (205 pages) : illustrations"]
[null,null,"Disciplina",null,"613.9/4"]
[null,null,"Soggetti",null,"Contraceptives - Research - United States"]
[{"$nulls":4},"Contraceptive drugs - Research - United States"]
[{"$nulls":4},"Contraception - trends"]
[{"$nulls":4},"Contraceptive Agents"]
[{"$nulls":4},"Contraceptive Devices"]
[{"$nulls":4},"Research"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Developing New Contraceptives -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- THE NEED FOR NEW CONTRACEPTIVES -- FDA REGULATION OF CONTRACEPTIVE PRODUCTS -- PRODUCTS LIABILITY LAW AFFECTING CONTRACEPTIVES -- CONCLUSION -- 1 Introduction -- ORGANIZATION -- 2 The Need for New Contraceptives -- CURRENT CONTRACEPTIVE USE -- Contraceptive Practice -- Contraceptive Effectiveness -- POTENTIAL EFFECTS OF NEW CONTRACEPTIVES -- Reducing Abortions -- Contraception and Health -- Reducing the Problems Associated with Existing Methods -- Increasing the Coverage and Quality of Contraceptive Services -- THE IMPORTANCE OF CONTRACEPTIVE DELIVERY -- CONCLUSION -- 3 The Current Status of Contraceptive Research -- RESEARCH LEADS -- Female Methods -- Male Methods -- Modifications of Existing Methods -- METHODS AVAILABLE OUTSIDE "]
[{"$nulls":4},"THE UNITED STATES -- CONCLUSION -- 4 Values and Contraceptive Development -- ROOTS OF AMERICAN VALUES ON CONTRACEPTION -- Historical Perspectives -- Religious Perspectives -- Legal Perspectives -- CONTEMPORARY VALUE CONFLICTS: STERILIZATION AND ABORTION -- The Link Between Contraceptive Development and Abortion -- RU-486 -- WOMEN'S PERSPECTIVES ON REPRODUCTION AND SOCIAL ROLES -- CONCLUSION -- 5 Organizational Structure of Contraceptive Development -- A DIVERSITY OF EXPERTISE -- The Pharmaceutical Industry -- Small Firms -- Universities -- Nonprofit Organizations -- Government and Private Funding Organizations -- The World Health Organization -- COLLABORATIVE EFFORTS IN CONTRACEPTIVE DEVELOPMENT -- Industry-University Collaboration -- Competitive Aspects of Contraceptive Development -- International Collaboration -- STRENGTHENING THE PROCESS OF CONTRACEPTIVE DEVELOPMENT -- Developing Country Institutions -- National Scientific Centers in the United States -- CONCLUSION -- 6 Funding for Contraceptive Development."]
[{"$nulls":4},"FUNDING FOR CONTRACEPTIVE DEVELOPMENT -- Pharmaceutical Industry Funding -- Federal Funding -- Foundation Funding -- Funding Worldwide -- World Health Organization -- TRAINING -- RECOMMENDATIONS -- CONCLUSION -- 7 Regulation and Contraceptive Development -- THE DEVELOPMENT PROCESS -- THE REGULATION PROCESS -- FDA's Regulation of Drugs -- Standards of Approval: Safety -- Toxicological Testing of Contraceptive Drugs -- The Case of Depo-Provera -- The Appropriateness of Current Safety Requirements for Contraceptive Drugs -- Standards of Approval: Effectiveness -- The Risk-Benefit Trade-off -- Patent Life and Profitability -- FDA's Regulation of Medical Devices -- Impediments to FDA Approval -- Postmarketing Surveillance -- CONTRACEPTIVE REGULATION: AN INTERNATIONAL PERSPECTIVE -- Regulation in Europe -- Regulation in Developing Countries -- The World Health Organization's Role -- RECOMMENDATIONS -- CONCLUSION -- 8 Products Liability and Contraceptive Development -- THE LEGAL TERRAIN -- SOURCES OF DATA -- TRENDS IN LITIGATION INVOLVING CONTRACEPTIVES -- Intrauterine Devices -- Oral Contraceptives -- Other Contraceptives -- PRODUCTS LIABILITY RULES -- Warranty -- Fraudulent Misrepresentation -- Negligence -- Strict Liability in Tort -- CASE STUDIES -- The Dalkon Shield Intrauterine Device -- Other Intrauterine Devices -- Oral Contraceptives -- Other Contraceptives -- PRODUCTS LIABILITY INSURANCE AND CONTRACEPTIVE DEVELOPMENT -- Causes of the Insurance Crisis -- Cost and Availability of Liability Insurance for Contraceptives -- Responses to the Crisis -- Responses by Insurers -- Responses by Policy Holders -- Responses by State Legislatures -- CONCLUSIONS AND RECOMMENDATIONS -- Possible Elements of a Statute -- The FDA Defense -- Effect on Products Liability Cases -- CONCLUSION -- 9 Contraceptive Development: Obstacles and Opportunities."]
[{"$nulls":4},"THE NEED FOR NEW METHODS -- RESEARCH LEADS -- VALUES -- ORGANIZATIONS AND RESOURCES -- REGULATION -- LIABILITY -- A FINAL WORD -- References -- Legal Cases Related to Contraceptive Development -- Glossary -- Index."]